Reseligo 10,8 mg implantat v napolnjeni injekcijski brizgi Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

reseligo 10,8 mg implantat v napolnjeni injekcijski brizgi

alvogen ipco s.ar.l - goserelin - implantat - goserelin 10,8 mg / 1 brizga - goserelin

Reseligo 3,6 mg implantat v napolnjeni injekcijski brizgi Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

reseligo 3,6 mg implantat v napolnjeni injekcijski brizgi

alvogen ipco s.ar.l - goserelin - implantat - goserelin 3,6 mg / 1 brizga - goserelin

Zoladex 10,8 mg implantat v napolnjeni injekcijski brizgi Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zoladex 10,8 mg implantat v napolnjeni injekcijski brizgi

astrazeneca ab - goserelin - implantat - goserelin 10,8 mg / 1 brizga - goserelin

Zoladex 3,6 mg implantat v napolnjeni injekcijski brizgi Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zoladex 3,6 mg implantat v napolnjeni injekcijski brizgi

astrazeneca ab - goserelin - implantat - goserelin 3,6 mg / 1 brizga - goserelin

Degarelix Accord Evropska unija - slovenščina - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - prostatične neoplazme - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Firmagon Evropska unija - slovenščina - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degareliks - prostatične neoplazme - endokrini terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Leptoprol 5 mg implantat v napolnjeni injekcijski brizgi Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

leptoprol 5 mg implantat v napolnjeni injekcijski brizgi

sandoz d.d. - levprorelin - implantat - levprorelin 5 mg / 1 brizga - levprorelin

Pamorelin 22,5 mg prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pamorelin 22,5 mg prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje

ipsen pharma - triptorelin - prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje - triptorelin 22,5 mg / 1 viala - triptorelin

Camcevi Evropska unija - slovenščina - EMA (European Medicines Agency)

camcevi

accord healthcare s.l.u. - leuprorelin mesilate - prostatične neoplazme - endokrini terapija - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

BICKAM 50 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bickam 50 mg filmsko obložene tablete

generics (uk) ltd. - bikalutamid - filmsko obložena tableta - bikalutamid 50 mg / 1 tableta - bikalutamid